iifl-logo

News Overview

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App
image

The government is expected to extend incentives for buying affordable homes priced up to Rs.45 lakh by a year, which will be excellent news for the affordable segment. Demand for the segment will rise as a result of the decision.

image

SGX Nifty: Trading of Nifty 50 index futures on the Singapore stock exchange indicates that the Nifty could slide 73 points at the opening bell. Global markets: Overseas, Asian stocks are trading lower on Friday as the recent rally in U.S. stocks broke momentum with the Nasdaq snapping a three-day winning streak. China released trade data on Friday, which showed that its dollar-denominated exports grew […]

image

Both Net Interest Income (NII) and Non-Interest Income are likely to clock in double-digit growth on a YoY basis.

image

These companies stock will be in focus today on stock exchanges amid Q3.

image

Rakesh has most recently worked at Visa Middle East FZ LLC (“Visaâ€), where he led commercial solutions for the CEMEA region, and was associated with Visa for a period of seven years.

image

Asian markets opened in the red led by the Japanese 'Nikkei' which traded lower by over 450 points in early trade.

image

Here is the important stock market news to watch out for today.

image

Check out the stocks that will be in focus during trade today based on recent and latest news developments.

image

Can Fin Homes will hold a meeting of the Board of Directors of the Company on 25 January 2022

image

Alembic Pharmaceuticals announced that it has received tentative approval from the US Food Drug Administration USFDA for its Abbreviated New Drug Application ANDA for Dronedarone Tablets USP 400 mg The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product RLD Multaq Tablets 400 mg of Sanofi-Aventis US LLC SanofiAventis Dronedarone is indicated to reduce the risk of hospitalization for atria fibrillation in […]

Download App
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.